Physician profile
Chelcia Wright
NPI 1053702282
$681.25
in general payments reported to CMS, 2019-2025
13 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2023: $147 · 2024: $291 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $124.97 | 2024 | Nuzyra |
| Phathom Pharmaceuticals, INC. | $120.84 | 2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $74.85 | 2023-2024 | |
| Upsher-Smith Laboratories LLC | $73.19 | 2021 | |
| Janssen Pharmaceuticals, INC | $59.44 | 2024 | Spravato |
| Exact Sciences Corporation | $48.96 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $32.86 | 2023-2024 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.33 | 2023-2024 | Jardiance |
| Lilly USA, LLC | $29.69 | 2021 | |
| Edwards Lifesciences Corporation | $26.40 | 2024 | |
| Abbvie INC. | $25.84 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $20.38 | 2023 | Rexulti |
| Astrazeneca Pharmaceuticals Lp | $13.50 | 2024 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelcia Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.